The non-nucleoside reverse transcriptase inhibitor Efavirenz triggers activation of inflammatory and fibrogenic signaling cascades in hepatic stellate cells
Por:
Alegre, F, Marti-Rodrigo, A, Polo, M, Milian-Medina, L, Apostolova, N, Esplugues, J and Blas-Garcia, A
Publicada:
1 oct 2015
Resumen:
Filiaciones:
:
Univ Valencia FISABIO, Pharmacol, Valencia, Spain
:
Univ Valencia, Pharmacol, Valencia, Spain
:
Univ Valencia FISABIO, Pharmacol, Valencia, Spain
:
Univ Valencia FISABIO, Pharmacol, Valencia, Spain
:
CIBERehd, Valencia, Spain
Jaume I Univ, Castellon de La Plana, Spain
:
Univ Valencia FISABIO, Pharmacol, Valencia, Spain
CIBERehd, Valencia, Spain
:
Univ Valencia FISABIO, Pharmacol, Valencia, Spain
CIBERehd, Valencia, Spain
|